1. Brodie, B.B. and Reid, W.D.: The value of determining the plasma concentration of drugs in animals and man. Drug Metabolism and Drug Disposition, La Du, B.N., Mandel, H.G. and Way, E.L. (eds), Williams & Wilkins Company, 1971, pp. 328–339.
2. Levy, G. and Matsuzawa, T.: Pharmaco kinetics of salicylamide elimination in man. J. Pharmacol. Exp. Ther., 156: 285–293, 1967.
3. Zilly, W., Brachtel, D., Löffler, R. und Richter, E.: Hexobarbitaltoleranz und Hexobarbital plasmaspiegel bei Patienten mit akuter Hepatitis während kontinuierlicher Hexobarbitalinfusion. Z. Gastroenterol., 11: 381–384, 1973. S
4. Hvidberg, E.F., Andreasen, P.B. and Ranek, L.: Plasma half-life of phenylbutazone in patients with impaired liver function. Clin. Pharmacol. Ther., 15: 171–177, 1974.
5. Andreasen, P.B., Ranek, L., Statland, B.E. and Tygstrup, N.: Clearance of antipyrine-de pendence of quantitative liver function. Eur. J. Clin. Invest., 4: 129–134, 1974.